Scientists hunt for hidden antibodies in Kids' kidney disease
NCT ID NCT07516964
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is investigating whether certain autoantibodies, especially those targeting a protein called nephrin, play a role in nephrotic syndrome, a kidney condition that causes swelling and protein loss in urine. Researchers will analyze blood and kidney tissue from 50 children and adults with the disease using advanced lab techniques. The goal is to better understand the disease mechanisms and pave the way for more personalized, effective treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this research could lead to better diagnostic tests and more personalized treatments for children with nephrotic syndrome, reducing unnecessary steroid use.
- What could go wrong
- This is an observational study, not a treatment trial. It is small (50 participants) and early-stage, so findings may not apply to all patients or lead directly to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLLAPSING GLOMERULOPATHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Azienda Ospedaliero Universitaria Careggi
NOT_YET_RECRUITINGFlorence, Italy
-
Azienda Ospedaliero Universitaria Pisana
NOT_YET_RECRUITINGPisa, Italy
-
Azienda Ospedaliero-Universitaria di Parma
NOT_YET_RECRUITINGParma, Italy
-
Azienda USL - IRCCS
NOT_YET_RECRUITINGReggio Emilia, Italy
-
Bellvitge University Hospital
NOT_YET_RECRUITINGBarcelona, Spain
-
Hospital General de México, Mexico City
NOT_YET_RECRUITINGMexico City, Mexico
-
IRCCS Azienda Ospedaliero - Universitaria
NOT_YET_RECRUITINGBologna, Italy
-
IRCCS Istituto Giannina Gaslini
NOT_YET_RECRUITINGGenova, Italy
-
Ludwig-Maximilians Universitat
NOT_YET_RECRUITINGMünchen, Germany
-
Mayo Clinic
NOT_YET_RECRUITINGRochester, Minnesota, 55902, United States
-
Meyer Children's Hospital IRCCS
RECRUITINGFlorence, FIRENZE, 50139, Italy
-
Ospedale S. Giovanni di Dio
NOT_YET_RECRUITINGFlorence, Italy
-
Ospedale Santa Maria Annunziata
NOT_YET_RECRUITINGBagno a Ripoli, Firenze, Italy
-
Ospedale Santo Stefano
NOT_YET_RECRUITINGPrato, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Immune cells may hold key to predicting kidney disease relapse
- New pill aims to plug protein leak in kidney patients
- New drug aims to stop kidney disease relapses
- New pill aims to plug kidney leaks in rare disease
- Personalized trial matching could revolutionize kidney disease treatment
- New study aims to measure swelling in kidney disease patients